UNSPSC 51102814: Aloe/hydrocortisone/iodoquinol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102814 Aloe/hydrocortisone/iodoquinol is a Commodity code that encompasses pharmaceutical products and medical supplies procured by state and local health departments, county public health agencies, and emergency services. The recent opportunities posted under this code show state and local governments buying pharmaceutical products through cooperative purchasing vehicles and direct procurement — including antimicrobial tablets, naloxone, and drug deactivation systems for community health and emergency response use. Issuing bodies include state health departments and county health agencies operating community health facilities and emergency response programs.

Recent activity appears sparse under this specific code. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, valued at $2,999,999.11 over three years, for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse cooperative purchasing consortium under an Invitation for Bid process. Seminole County, Florida issued an IFB in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a two-year initial term with one-year renewal option. Activity centers on Illinois and Florida, though the code's recent posting volume remains limited and suggests that state and local pharmaceutical procurement under this specific commodity designation is not presently concentrated.